Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 258

1.

Age-specific cancer incidence rates increase through the oldest age groups.

Thakkar JP, McCarthy BJ, Villano JL.

Am J Med Sci. 2014 Jul;348(1):65-70. doi: 10.1097/MAJ.0000000000000281.

2.

Let's Get This Party Started: The Effects of Descriptive and Injunctive Norms on Preparty Behavior in College Students.

Rutledge PC, McCarthy BJ, Lendyak RM.

Subst Use Misuse. 2013 Aug 21. [Epub ahead of print]

PMID:
23964986
4.

Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.

Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, Melin BS, Bondy ML; Gliogene Consortium.

Eur J Cancer. 2013 Apr;49(6):1335-45. doi: 10.1016/j.ejca.2012.11.009. Epub 2013 Jan 4.

5.

A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma.

Sun X, Vengoechea J, Elston R, Chen Y, Amos CI, Armstrong G, Bernstein JL, Claus E, Davis F, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lai R, Lau CC, Liu Y, McCarthy BJ, Olson SH, Sadetzki S, Schildkraut J, Shete S, Yu R, Vick NA, Merrell R, Wrensch M, Yang P, Melin B, Bondy ML, Barnholtz-Sloan JS; Gliogene Consortium.

Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2242-51. doi: 10.1158/1055-9965.EPI-12-0703. Epub 2012 Sep 7.

6.

Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007.

Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL, Ajani UA.

Cancer. 2012 Sep 1;118(17):4220-7. doi: 10.1002/cncr.27390. Epub 2012 Jan 3.

7.

Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data.

Davis FG, Dolecek TA, McCarthy BJ, Villano JL.

Neuro Oncol. 2012 Sep;14(9):1171-7. doi: 10.1093/neuonc/nos152. Epub 2012 Aug 16.

8.

Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries.

McCarthy BJ, Shibui S, Kayama T, Miyaoka E, Narita Y, Murakami M, Matsuda A, Matsuda T, Sobue T, Palis BE, Dolecek TA, Kruchko C, Engelhard HH, Villano JL.

Neuro Oncol. 2012 Sep;14(9):1194-200. doi: 10.1093/neuonc/nos155. Epub 2012 Aug 6.

9.

Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma.

Liu Y, Melin BS, Rajaraman P, Wang Z, Linet M, Shete S, Amos CI, Lau CC, Scheurer ME, Tsavachidis S, Armstrong GN, Houlston RS, Hosking FJ, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, LaChance D, Vick NA, Wrensch M, Davis F, McCarthy BJ, Andersson U, Thompson PA, Chanock S; Gliogene Consortium, Bondy ML.

Hum Genet. 2012 Sep;131(9):1507-17. Epub 2012 Jun 12.

10.

Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.

Shete S, Lau CC, Houlston RS, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Sadetzki S, Johansen C, Bernstein JL, Olson SH, Jenkins RB, Yang P, Vick NA, Wrensch M, Davis FG, McCarthy BJ, Leung EH, Davis C, Cheng R, Hosking FJ, Armstrong GN, Liu Y, Yu RK, Henriksson R; Gliogene Consortium, Melin BS, Bondy ML.

Cancer Res. 2011 Dec 15;71(24):7568-75. doi: 10.1158/0008-5472.CAN-11-0013. Epub 2011 Oct 28.

11.

Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study.

Hofmann JN, Baccarelli A, Schwartz K, Davis FG, Ruterbusch JJ, Hoxha M, McCarthy BJ, Savage SA, Wacholder S, Rothman N, Graubard BI, Colt JS, Chow WH, Purdue MP.

Br J Cancer. 2011 Nov 22;105(11):1772-5. doi: 10.1038/bjc.2011.444. Epub 2011 Oct 27.

12.

Update on meningiomas.

Saraf S, McCarthy BJ, Villano JL.

Oncologist. 2011;16(11):1604-13. doi: 10.1634/theoncologist.2011-0193. Epub 2011 Oct 25. Review.

13.

Improved survival time trends for glioblastoma using the SEER 17 population-based registries.

Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ.

J Neurooncol. 2012 Mar;107(1):207-12. doi: 10.1007/s11060-011-0738-7. Epub 2011 Oct 9.

14.

Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.

Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ.

Br J Cancer. 2011 Oct 25;105(9):1414-8. doi: 10.1038/bjc.2011.357. Epub 2011 Sep 13.

15.

Conditional survival of all primary brain tumor patients by age, behavior, and histology.

Porter KR, McCarthy BJ, Berbaum ML, Davis FG.

Neuroepidemiology. 2011;36(4):230-9. doi: 10.1159/000327752. Epub 2011 Jun 16.

16.

Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system.

Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK.

J Natl Cancer Inst. 2011 May 4;103(9):714-36. doi: 10.1093/jnci/djr077. Epub 2011 Mar 31.

17.

Assessment of type of allergy and antihistamine use in the development of glioma.

McCarthy BJ, Rankin K, Il'yasova D, Erdal S, Vick N, Ali-Osman F, Bigner DD, Davis F.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):370-8. doi: 10.1158/1055-9965.EPI-10-0948.

18.

Risk factors for oligodendroglial tumors: a pooled international study.

McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H, Feychting M, Il'yasova D, Inskip PD, Johansen C, Melin BS, Ruder AM, Butler MA, Scheurer ME, Schüz J, Schwartzbaum JA, Wrensch MR, Davis FG.

Neuro Oncol. 2011 Feb;13(2):242-50. doi: 10.1093/neuonc/noq173. Epub 2010 Dec 10.

19.

Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology.

Porter KR, McCarthy BJ, Freels S, Kim Y, Davis FG.

Neuro Oncol. 2010 Jun;12(6):520-7. doi: 10.1093/neuonc/nop066. Epub 2010 Feb 8.

20.

Prediagnosis food patterns are associated with length of survival from epithelial ovarian cancer.

Dolecek TA, McCarthy BJ, Joslin CE, Peterson CE, Kim S, Freels SA, Davis FG.

J Am Diet Assoc. 2010 Mar;110(3):369-82. doi: 10.1016/j.jada.2009.11.014.

PMID:
20184987

Supplemental Content

Loading ...
Support Center